JPRN-UMIN000018919招募中2 期
Phase II trial of biweekly THP-COP therapy for patients with peripheral T-cell lymphomas. - Biweekly THP-COP therapy for peripheral T-cell lymphomas
Kanagawa Clinical Oncology study Group0 个研究点目标入组 40 人开始时间: 2015年9月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Severe infection, active tuberculosis, uncontrollable diabetes mellitus under insulin treatment, or liver cirrhosis (2) Other active malignancy (except for in situ carcinoma in uterine cervix or basal cell carcinoma) (3) CNS involvement (4) Pregnant or breastfeeding women (5) Severe psychosis (6) HBs antigen positive (7) HBc antibody positive or HBs antibody positive, with HBV-DNA positive (8) HIV antibody positive or HTLV-1 antibody positive (9) Patients with difficult situation for study such as high-risk of gastrointestinal perforation/bleeding or surgical indication
研究者
相似试验
已完成
2 期
Phase II study of a full-dose THP-COP regimen for aggressive non-Hodgkin lymphoma in the elderlyJPRN-UMIN000005636Hematological Malignancy Clinical Study Group30
已完成
2 期
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphomaPeripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphomaJPRN-UMIN000010485Yokohama City University Hopsital20
招募中
2 期
The randomized controlled trial of the THP-COP therapy versus CHOP therapy for T-cell lymphoma with or without P-glycoprotein expressioT cell LymphomaJPRN-UMIN000004092Osaka Lymphoma Study Group94
招募中
2 期
Phase-2 clinical trial on the treatment of chronic dysphagia in head and neck cancer patients with dedicated strengthening exercises using the Swallow Exercise AidDysphagiaswallowing impairment10027656NL-OMON42230Antoni van Leeuwenhoek Ziekenhuis20
已完成
2 期
The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III studydiffuse large B-cell lymphomaJPRN-UMIN000007283Gifu University Hospital80